List of works by Ken Suzawa

Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

scientific article

Activation of KRAS mediates resistance to targeted therapy in MET ex on 14 mutant non-small cell lung cancer

article

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations

scientific article

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis

scientific article published on 06 October 2018

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies

scientific article published on January 2017

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

scientific article published on 26 July 2017

Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.

scientific article published on 23 November 2015

Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods

scientific article published on 17 July 2017

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.

scientific article

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.

scientific article published on 23 December 2016

MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions

scientific article published on 02 March 2020

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system

scientific article

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.

scientific article published on 13 January 2017

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

scientific article published on 15 April 2018

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.

scientific article published on 13 March 2018

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

scientific article

Paulina is supported by:

About Paulina

Help